By Dr. Brandon Bright, DAOM, LAc · Doctor of Acupuncture & Oriental Medicine · Functional Medicine University-certified · Clinical Hypnotherapist · Tustin, CA · Last reviewed: June 8, 2026
On June 4, 2026, Hims & Hers closed its $1.15 billion acquisition of Eucalyptus — the Australian-founded telehealth platform that operates Pilot, Juniper, Software, Compound, and Kin across nine countries. The combined company now reaches patients in the US, UK, Australia, Germany, France, Japan, Ireland, Canada, and New Zealand. If you’ve been thinking about Hims for GLP-1 weight loss, hair, ED, hormone therapy, or any of the other categories the platform now spans, this is the moment to understand what you’re signing up for — and what the FDA’s regulatory pressure on compounded medications means for the model.
The 55-Second Answer
Hims + Eucalyptus is the largest direct-to-consumer telehealth platform in the world right now. It works well for routine, well-understood prescription needs at a low price point. It is not built for complex multi-system care, longevity protocol design, or comprehensive functional medicine workup. Patients who use the platform without understanding the difference get a fast Rx and miss the work that actually moves chronic-illness outcomes. Patients who use it as one tool inside a broader strategy can benefit from the convenience.
The model is also under real regulatory pressure on compounded GLP-1s, which matters if weight loss is why you’re considering it.
What Actually Changed on June 4
Hims & Hers is now a category-spanning international telehealth platform, not a US-only men’s-health brand. The 9-country footprint matters because it spreads regulatory exposure — the FDA can pressure compounded GLP-1 supply, but Eucalyptus has European and Australasian operations to fall back on. Wall Street priced the deal as a hedge against US-only regulatory tightening. From a patient perspective, the consolidation means three things:
1. The platform now covers more conditions than any single previous DTC telehealth company. Mental health, dermatology, hair, sexual health, hormone therapy for men and women, weight loss (compounded GLP-1s including semaglutide and tirzepatide where permitted), sleep, hangover support, sexual wellness products. Whatever you came in for, the platform will offer cross-sell suggestions across the catalog.
2. The Rx pathway is fast and asynchronous. A licensed clinician in your state reviews your intake, prescribes if appropriate, and the medication ships. The fast turnaround works because the platform has standardized the easy cases. If your case is not easy, the same fast pathway can mean a less-than-thorough workup.
3. Pricing is well below in-person care for most categories. Compounded GLP-1 plans typically run $199-$299/month including medication, syringes, and the clinician layer. ED meds and hair plans start under $30/month. The pricing pressure is real and it’s why the platform has grown so fast.
The Honest Comparison
Here’s how the three main paths actually differ for an Orange County patient comparing options in 2026:
| Dimension | Hims + Eucalyptus | Function Health | Clinician-led care (Tustin / OC) |
|---|---|---|---|
| Cost | $30-$299/month depending on category | $499/year for bloodwork + AI interpretation | $199 in-person initial / $150 virtual + protocol cost |
| What you get | Fast Rx for the condition you came in for | Comprehensive bloodwork + AI interpretation layer | Multi-system intake, custom protocol, in-person modalities (acupuncture, hypnotherapy, peptides, herbs) |
| Clinician relationship | Asynchronous review by a licensed clinician you don’t meet | Asynchronous AI + optional clinician add-on | Direct relationship with a DAOM clinician who knows your history |
| Compounded medication exposure | High — compounded GLP-1s are central to the weight-loss product | None — Function Health is a testing service | Selective — research-grade peptides used clinically; no 503A weight-loss compounding |
| Best for | Single, well-understood condition; cost-sensitive; standard treatment is appropriate | Patients who want deep bloodwork data | Complex cases, chronic illness, longevity protocol design, multi-modality care |
| Not built for | Complex multi-system workup, chronic illness root-cause work | Anything that isn’t testing data | The patient who wants $30/month convenience |
| Regulatory exposure | FDA pressure on compounded GLP-1 supply (real, ongoing) | Low — data layer doesn’t carry prescribing risk | Low — within scope of DAOM/LAc licensure |
| Geographic limits | 9 countries; US presence in all states with telehealth | US-wide bloodwork shipping | In-person Tustin / virtual statewide California |
The comparison isn’t “which one is better.” It’s “which one matches your situation.” All three have legitimate roles for the right patient.
The Regulatory Pressure on Compounded GLP-1 You Should Know About
This is the part the Hims marketing doesn’t lead with, and it’s the part that matters most if weight loss is why you’re considering the platform.
Compounded semaglutide and compounded tirzepatide became widely available during the FDA-declared shortage of the branded products (Wegovy, Ozempic, Mounjaro, Zepbound). The shortage was officially resolved by the FDA in late 2024, which legally restricted 503A and 503B compounding pharmacies from producing copycat versions — with some exceptions for personalized dosages or formulations not commercially available.
In April-May 2026, the FDA tightened that framework further with a 503B proposed rule that would exclude compounded GLP-1s from outsourcing-facility production except under narrow clinical-need conditions. The agency is taking comments through July 15, 2026. I’m filing a 503B comment myself.
What this means for the Hims + Eucalyptus model:
The compounded GLP-1 supply that feeds the platform is structurally fragile. Multiple supply paths have already been disrupted in 2025-2026 as the FDA enforces against non-personalized compounding. If you start a Hims GLP-1 plan in June 2026, your ongoing supply over the next 6-18 months depends on how the regulatory pressure resolves.
The pricing advantage is partly a regulatory arbitrage. Compounded versions are cheaper than branded Wegovy or Zepbound at retail. That price gap exists partly because the compounded version doesn’t carry the same clinical-trial cost structure or the same scale of supply-chain build-out. If the regulatory framework continues to tighten, the price differential narrows.
The clinical-monitoring layer is asynchronous by design. GLP-1 weight loss is most successful when it’s combined with structured nutrition support, muscle-preservation work, and adherence to a sustainable protocol. The Hims model handles the prescription; the surrounding work is on the patient. For patients who are organized, that’s fine. For patients who need scaffolding, the platform’s design doesn’t provide it.
None of this means Hims is wrong for everyone. It means the model carries specific risk you should understand before you start.
When Hims Is the Right Call
I want to be fair here. The Hims platform genuinely works for some patients.
Standard, well-understood prescription needs. If you’ve previously been on the medication, you know how you respond, and you just need an efficient supply path — Hims is fine. ED meds, hair, sleep aids, certain dermatology conditions fit this pattern.
Budget is the binding constraint. If your alternative is “don’t get the treatment at all because in-person costs are too high,” a $30-$199/month telehealth path is meaningfully better than no treatment. The platform exists because access has been a real problem.
Single-condition focus. If you’re only addressing the one condition and don’t need integration with broader health context, the focused product line works.
When Clinician-led Care Is the Better Fit
Complex or chronic cases. Long COVID, post-viral syndromes, MCAS, perimenopause, autoimmune conditions, post-concussion syndrome, complex pain. The fast asynchronous model isn’t built for the workup these conditions require.
Multi-system or longevity protocol work. When the goal is structured intervention across nutrition, hormones, supplements, sleep, stress, and recovery — not just one symptom — the protocol design needs more than a 15-minute intake.
You want a real relationship with the clinician. Some patients value the asynchronous convenience; others want a clinician who knows their history, recognizes their pattern, and can adjust the protocol over months and years. That relationship doesn’t form through a portal.
You want the in-person modalities. Acupuncture for autonomic regulation and pain. Hypnotherapy for sleep, anxiety, performance. Herbal formulas calibrated to your specific pattern. Research-grade peptides used selectively and clinically. The Hims model doesn’t carry any of this.
You’re in Orange County. The Tustin practice exists specifically to do this kind of work for OC patients who want clinician-led care that isn’t either of the two extremes (cheap-telehealth-Rx-mill on one side, $20,000/year concierge on the other).
What I’d Tell a Patient Asking This Week
If you’re looking at Hims for ED, hair, or a standard dermatology condition: the platform is reasonable. Read your intake carefully, understand what you’re being prescribed, and use it as one tool among many.
If you’re looking at Hims for compounded GLP-1 weight loss: understand the regulatory pressure, understand the supply fragility, and have a plan B for what you’ll do if the supply path tightens. Also think honestly about whether you need the scaffolding that the asynchronous model doesn’t provide. For many patients, structured in-person or hybrid care produces better long-term outcomes than fast-Rx-and-go.
If you’re looking at the platform because you don’t know where else to start: that’s the most important place to slow down. The first decision in health care isn’t “what should I take.” It’s “what’s actually going on, and what’s the right plan for me.” That work is what clinician-led care exists to do.
Frequently Asked Questions
Is Hims a real clinic? Hims is a telehealth platform that connects you to licensed clinicians in your state. The clinicians are real and licensed; the relationship is asynchronous and product-focused.
Will Hims supply compounded GLP-1 forever? Unknown. The regulatory framework is tightening. The 503B proposed rule with the July 15, 2026 comment deadline is the next major signal.
Can I combine Hims with in-person clinician care? Some patients do — they use Hims for routine prescription needs and a local clinician for the complex work. That’s not a wrong answer for the right situation, as long as both sides know what you’re doing.
What’s the difference between Function Health and Hims? Different categories. Function Health is bloodwork plus AI interpretation. Hims is asynchronous Rx for treatable conditions. They don’t compete with each other; they don’t replace each other; many patients use both alongside clinician-led care.
Where should I start if I want a longevity protocol and not just a prescription? Start with comprehensive bloodwork (Function Health is the most-used path), then layer clinician-led protocol design on top. The Tustin practice offers this hybrid for OC patients. Telehealth platforms like Hims aren’t built for protocol design.
Are you against telehealth? No. I run virtual visits for California patients at $150 initial. The model has a real role. What I’m against is patients using fast-Rx telehealth as a substitute for the workup that complex cases require.
What to Do This Week
If you’re a Hims customer for a standard condition: keep going, eyes open on the regulatory side.
If you’re considering Hims for GLP-1: read the FDA 503B background before you start. Have a plan B.
If you’re in Orange County and you want clinician-led functional medicine, acupuncture, hypnotherapy, or peptide therapy from a DAOM clinician: book a first visit at the Tustin practice. $199 in-person initial, $150 virtual. We accept cash, HSA/FSA, and provide superbills for out-of-network insurance reimbursement.
If you want a comprehensive longevity protocol designed for you specifically: join the AI Longevity Pro beta — 90-day complimentary period.
Dr. Brandon Bright, DAOM, LAc
Holistic and integrative medicine practitioner serving Tustin and patients nationwide.